Interesting facts
Interesting Facts about 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine
6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine is a fascinating compound that belongs to the class of benzodiazepines, which are well-known for their pharmacological properties. Here are some intriguing insights about this particular compound:
- Structure and Composition: This compound's structure presents a complex arrangement comprising a benzo[b][1,4]benzodiazepine core with a piperazine substituent. The integration of a methylpiperazine group plays a significant role in enhancing its bioactivity.
- Pharmacological Potential: Molecules in the benzodiazepine family are often associated with therapeutic effects, such as anxiolytic, sedative, and muscle relaxant properties. Research into this compound might unveil its potential applications in treating various central nervous system disorders.
- Research Interest: Compounds like 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine are often of considerable interest in medicinal chemistry. Scientists strive to optimize their effects while minimizing side effects, a challenging yet rewarding pursuit.
- Innovation in Drug Design: The design of derivatives based on this structure could lead to the development of new medications with tailored pharmacological profiles that can address specific health conditions more effectively.
In summary, 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine serves as an example of how intricate molecular designs can lead to significant advancements in therapeutic chemistry. Researchers continue to explore the vast potential of such compounds, pushing the boundaries of what is possible in medicine.
Synonyms
1977-07-7
11-(4-Methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
BRN 0761696
DTXSID80173463
5H-DIBENZO(b,e)(1,4)DIAZEPINE, 11-(4-METHYL-1-PIPERAZINYL)-
5-25-11-00363 (Beilstein Handbook Reference)
11-(4-Methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine
5H-Dibenzo[b,e][1,4]diazepine, 11-(4-methyl-1-piperazinyl)-
DTXCID6095954
106-094
Deschloroclozapine
11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
Dopamine serotonin antagonist-1
6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine
CHEMBL73538
11-(4-Methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0(3),?]pentadeca-1(11),3,5,7,9,12,14-heptaene
DCZ
MFCD01730958
Deschloroclozapine (DCZ)
L8J8TZV54G
SCHEMBL141020
VQHITFFJBFOMBG-UHFFFAOYSA-N
BAA97707
CS-M3647
BDBM50010591
HB8555
AKOS027427703
AS-70338
DA-52663
HY-42110
C73760
(E)-11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
Solubility of 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine
The solubility of the compound 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine can be intriguing and complex. Understanding its solubility characteristics is crucial for its applications and behavior in various settings. Here are some key points to consider:
In conclusion, the solubility of 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine is influenced by multiple factors, making its solvation characteristics a vital aspect in the study and application of this compound. Further experimentation will be essential to establish a thorough understanding of its solubility profile.